US Corporate Distress Financial Stress SEC Filings — February 25, 2026

26-02-2026

Zura Bio Ltd filed a Form 8-K on 2026-02-26 disclosing entry into a Material Definitive Agreement under Item 1.01, Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01 (AccNo: 0001104659-26-019827, size 744 KB). This is a multi-item filing covering a material transaction alongside financial updates, but specific details including transaction value, financial metrics, and performance changes are NOT_DISCLOSED. No quantitative impacts or period-over-period comparisons are available.

• ·Multi-item 8-K filing
• ·Sector: NOT_DISCLOSED

26-02-2026

Avanos Medical, Inc. filed an 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or comparisons were disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative data available.

26-02-2026

Roadzen Inc. filed an 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement, transaction terms, parties, financial impacts, or metrics are disclosed. This is a multi-item mandatory disclosure with no quantitative data provided.

• ·Filing Accession Number: 0001493152-26-008128
• ·Filing Size: 319 KB

26-02-2026

MVB Financial Corp filed an 8-K on 2026-02-26 reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific details on the agreement, obligation size, terms, or financial impacts are disclosed in the provided information. This represents a multi-item mandatory disclosure with potential balance sheet implications, but lacks quantification.

26-02-2026

Arrow Financial Corp filed a Form 8-K on February 26, 2026 (AccNo: 0000717538-26-000030, Size: 48 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative metrics, transaction details, financial impacts, or period-over-period comparisons are disclosed. The large filing size suggests substantial exhibits, likely including the agreement text.

26-02-2026

Kymera Therapeutics, Inc. filed a Form 8-K on February 26, 2026, disclosing entry into a new material definitive agreement under Item 1.01, which could signal strategic advancements, but simultaneously reported termination of a prior material definitive agreement under Item 1.02, potentially indicating shifts or disruptions in existing commitments. The filing also covers other events (Item 8.01) and includes financial statements and exhibits (Item 9.01). No specific transaction values, financial impacts, or quantitative metrics are disclosed.

26-02-2026

Redwire Corp filed a multi-item 8-K on February 26, 2026, reporting entry into a new material definitive agreement (Item 1.01), termination of a prior material definitive agreement (Item 1.02), results of operations and financial condition (Item 2.02), and creation of a new direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits under Item 9.01. No specific details on the agreements, transaction values, financial metrics, or impacts are disclosed. This combination suggests both new commitments and terminations, but lacks quantification for balanced assessment.

26-02-2026

Zoomcar Holdings, Inc. filed a multi-item Form 8-K on 2026-02-26 disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), accompanied by Regulation FD disclosure (Item 7.01). While Item 1.01 signals a potentially strategic transaction, Item 3.02 raises dilution concerns from equity issuances. No transaction values, financial impacts, or specific details are disclosed.

26-02-2026

TIGO ENERGY, INC. filed an 8-K on 2026-02-26 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. Specific details of the material definitive agreement, other events, transaction size, financial impacts, or any quantitative metrics are NOT_DISCLOSED in the provided filing summary. No positive or negative performance metrics, comparisons, or guidance changes are mentioned.

26-02-2026

The company filed a Form 8-K on February 26, 2026 (AccNo: 0001193125-26-075834, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, parties, value, financial impacts, or strategic implications are provided.

• ·Multi-item filing: Items 1.01 and 9.01
• ·Event date matches filing date: February 26, 2026
• ·Filing size: 2 MB

26-02-2026

CHASE PACKAGING CORP filed an 8-K on 2026-02-26 disclosing Item 3.03 Material Modifications to Rights of Security Holders and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the modifications provided in the available information. No positive or negative performance metrics are mentioned.

26-02-2026

Bicara Therapeutics Inc. filed a Form 8-K on 2026-02-26 reporting entry into a material definitive agreement under Item 1.01 and results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, financial metrics, or performance comparisons provided in the available information. No positive or negative metrics are disclosed.

26-02-2026

Insight Molecular Diagnostics Inc. filed a Form 8-K on February 26, 2026 (AccNo: 0001493152-26-008169), disclosing entry into a material definitive agreement under Item 1.01 and providing financial statements and exhibits under Item 9.01. No details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

• ·Filing size: 202 KB
• ·Accession Number: 0001493152-26-008169
• ·Sector: NOT_DISCLOSED

26-02-2026

Teledyne Technologies Inc filed an 8-K on 2026-02-26 under Items 1.01 and 9.01, disclosing entry into a material definitive agreement with financial statements and exhibits attached. No details on the agreement's nature, parties, value, strategic rationale, or financial impacts are provided in the filing summary. No quantitative metrics, period-over-period changes, or scheduled events are mentioned.

26-02-2026

MP Materials Corp. filed an 8-K on February 26, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary. This appears to be a standard earnings-related disclosure without detailed financial data available.

26-02-2026

PLUG POWER INC filed an 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or guidance changes are mentioned.

26-02-2026

Brink's Co filed a Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement's nature, parties, terms, or financial impacts disclosed in the provided information. No quantitative metrics, period-over-period comparisons, or directional performance indicators (positive, negative, or flat) are mentioned.

26-02-2026

Seer, Inc. filed a multi-item Form 8-K on February 26, 2026, reporting entry into a material definitive agreement under Item 1.01, material modifications to rights of security holders under Item 3.03, amendments to articles of incorporation or bylaws under Item 5.03, and Regulation FD disclosure under Item 7.01, with exhibits under Item 9.01. No specific details on the agreement, modifications, amendments, financial impacts, or quantitative metrics are disclosed in the provided filing summary.

26-02-2026

TPG Inc. filed a Form 8-K on February 26, 2026, reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing triggered by significant corporate developments, but no specific transaction details, dollar values, financial metrics, or quantitative impacts are disclosed. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

26-02-2026

Phillips Edison & Company, Inc. filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, which are mandatory disclosures. Item 8.01 covers other events and Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed.

• ·Multi-item 8-K filing (Items 1.01, 2.03, 8.01, 9.01)
• ·Filed same day as event date (2026-02-26), indicating timely disclosure

26-02-2026

PureCycle Technologies, Inc. filed a multi-item Form 8-K on February 26, 2026, reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), material modifications to rights of security holders (Item 3.03), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This appears to be a comprehensive disclosure covering operational, governance, and strategic updates.

26-02-2026

Sidus Space Inc. filed a Form 8-K on 2026-02-26 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement's nature, parties, dollar value, strategic importance, or financial impacts are provided.

26-02-2026

Advanced Biomed Inc. filed an 8-K on February 26, 2026, disclosing under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, financial impacts, or quantitative metrics regarding these changes or events are provided. This is a multi-item filing with no disclosed positive or negative performance metrics.

26-02-2026

ITRON, INC. filed a Form 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure with no specific dollar values, share counts, terms, or financial metrics disclosed. Potential implications include strategic shifts, balance sheet changes, and equity dilution, but details are NOT_DISCLOSED.

26-02-2026

Mayville Engineering Company, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.

26-02-2026

NCR Atleos Corp filed an 8-K on 2026-02-26 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with a core event of entering a material agreement, accompanied by voluntary disclosure under Reg FD and attached exhibits. No quantitative metrics, financial impacts, transaction values, or specific details on the agreement are disclosed in the provided filing summary.

26-02-2026

MARA Holdings, Inc. filed a Form 8-K on 2026-02-26 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, or metrics disclosed. All quantitative data, including dollar values and percentages, are NOT_DISCLOSED.

26-02-2026

Grindr Inc. filed a Form 8-K on 2026-02-26 reporting entry into a material definitive agreement under Item 1.01 and results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction size, financial metrics, or performance provided in the available information. No positive or negative metrics are disclosed.

26-02-2026

Abbott Laboratories filed an 8-K on 2026-02-26 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or metrics are disclosed. This is a mandatory disclosure of a material event without quantified positive or negative elements.

26-02-2026

PPL Corp filed an 8-K on 2026-02-26 reporting entry into a Material Definitive Agreement under Item 1.01, accompanied by Financial Statements and Exhibits under Item 9.01. No details on the agreement parties, terms, value, strategic rationale, financial impacts, or other metrics are disclosed.

26-02-2026

CyberloQ Technologies, Inc. filed an 8-K on February 26, 2026 (AccNo: 0001493152-26-008185), reporting under Item 1.01 entry into a material definitive agreement. No additional details on the nature of the agreement, transaction value, financial impacts, parties involved, or strategic rationale were explicitly stated. No quantitative metrics, positive or negative changes, or comparisons were disclosed.

26-02-2026

Applied Optoelectronics, Inc. filed an 8-K on 2026-02-26 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details regarding the agreement's parties, terms, transaction value, financial impacts, or strategic context are disclosed in the provided filing summary. Review of the full 495 KB filing (AccNo: 0001104659-26-020600) is required for complete analysis.

26-02-2026

STONERIDGE INC filed a Form 8-K on 2026-02-26 reporting multiple items: Item 1.01 Entry into a Material Definitive Agreement, Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, personnel changes, disclosures, dollar values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with no period-over-period comparisons, guidance, or scheduled events mentioned.

26-02-2026

CenterPoint Energy Inc filed an 8-K on February 26, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 references attached financial statements and exhibits. No specific transaction values, financial impacts, positive or negative metrics, or other quantitative details are disclosed.

26-02-2026

Metropolitan Bank Holding Corp. filed a multi-item Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or disclosures are provided in the available metadata. This is an informational filing with no quantified metrics or period-over-period comparisons disclosed.

26-02-2026

Boston Scientific Corp filed a multi-item 8-K on February 26, 2026, disclosing entry into a material definitive agreement (Item 1.01) while terminating a prior material definitive agreement (Item 1.02). The filing also reports the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits under Item 9.01. No specific transaction values, parties, terms, or financial impacts are disclosed.

26-02-2026

Nixxy, Inc. filed an 8-K on 2026-02-26 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing. No financial metrics, transaction values, or other quantitative data disclosed. Sector not specified.

• ·Accession Number: 0001683168-26-001318
• ·Filing size: 239 KB

26-02-2026

CNX Resources Corp filed an 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. No specific transaction details, dollar values, financial metrics, or performance comparisons (positive, negative, or flat) were disclosed in the filing summary. This multi-item filing indicates significant corporate actions but lacks quantitative data for impact assessment.

26-02-2026

NKGen Biotech, Inc. filed a Form 8-K on February 26, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits, likely including the agreement. No quantitative details, financial impacts, positive or negative metrics, or further context on the transaction are provided.

26-02-2026

Macerich Co filed an 8-K on 2026-02-26 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or comparisons are disclosed.

26-02-2026

Vir Biotechnology, Inc. filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01, with exhibits under Item 9.01 (AccNo: 0001193125-26-077416, file size 442 KB). No specific details on the agreement terms, transaction value, financial impacts, or strategic rationale are provided. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

• ·File size: 442 KB
• ·Sector: not specified

26-02-2026

Palvella Therapeutics, Inc. filed an 8-K on 2026-02-26 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed.

• ·Filing Accession Number: 0001104659-26-020667
• ·File Size: 584 KB
• ·Event Date: 2026-02-26
• ·Sector: not specified
• ·Multi-item 8-K filing (Items 1.01 and 9.01)
• ·Mandatory disclosure under Item 1.01 for material agreements

26-02-2026

NuScale Power Corp filed an 8-K on February 26, 2026, reporting entry into a material definitive agreement under Item 1.01 while simultaneously disclosing termination of another material definitive agreement under Item 1.02. Item 9.01 provides financial statements and exhibits. This mixed disclosure signals potential strategic advancement from the new agreement but disruption from the termination, with no specific financial or operational details provided.

26-02-2026

FTAI Infrastructure Inc. filed an 8-K on 2026-02-26 disclosing entry into a material definitive agreement under Item 1.01 and termination of a material definitive agreement under Item 1.02. The filing also includes results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific transaction details, financial metrics, or quantitative impacts are disclosed.